VivArt-X is a biotechnology startup founded in 2022, with a focus on the development of regenerative materials for Women's Health. The company recently secured a €660.00KPre Seed Round investment from notable investors including Brabant Startup Fund, Eindhoven University of Technology, BOM on 16 November 2023. This injection of capital will likely bolster their research and development efforts, potentially accelerating their progress towards bringing innovative solutions to market.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Pre Seed Round - VivArt | €660.00K | 3 | Brabant Startup Fund, Eindhoven University of Technology +1 | 16 Nov 2023 |
No recent news or press coverage available for VivArt-X.